The joint commission "Antiviral Therapy" of the DVV and GfV deals with the most diverse aspects of antiviral prophylaxis and therapy. The commission is involved in updating existing guidelines and initiating new guidelines and informs the scientific community about current developments in antiviral therapy.


 Dr. Rolf Kaiser
University and University Hospital of Cologne
Institute of Virology
Fürst Pückler Straße 56
50935 Cologne
Tel. +49 (0) 221 - 478 85808

Vice Chair

Djin-Ye Oh, MD
Dept. 1, Infectious Diseases; FG17 (Influenza and Other Respiratory Virology)
Robert Koch Institute
Nordufer 20
13353 Berlin
Tel: +49 (0)30 - 18754 0
Fax: +49 (0)30 - 18754 2328


APL Prof. Dr. Michaela Schmidtke, Jena
Assoz. Prof. Dr. Judith Aberle, Wien
Prof. Dr. Ralf Bartenschlager, Heidelberg
Prof. Dr. Denisa Bojkova, Frankfurt am Main
Dr. Susanne Duwe, Berlin
Prof. Dr. med. Helmut Fickenscher, Kiel
Prof. Dr. Barbara Gärtner, Homburg/Saar
Dr. Katharina Göhring, Ulm
Prof. Dr. Oliver Keppler, München
Prof. Dr. Thomas Klimkait, Basel
Dr. Klaus Korn, Erlangen
PD Dr. Andi Krumbholz, Kiel
Prof. Dr. Thomas Mertens, Ulm
Dr. med. Martin Obermeier, Berlin
Prof. Dr. Thomas Pietschmann, Hannover Christiane Prifert, Halle
Prof. Dr. Jörg Timm, Düsseldorf
Prof. Dr. med. Ulrike Wieland, Köln
Prof. Dr. Peter Wutzler, Jena
Prof. Dr. John Ziebuhr, Gießen
Ständiger Gast der KAT-GfV/DVV: Dr. Holger Zimmermann, Wuppertal

Further information

Sicherheitsrelevante Forschung in der Virologie

Die “Kommission für sicherheitsrelevante Forschung in der Virologie” (ehemals “Virologische Forschung mit „Dual-Use“ Potential”) informiert die virologische Wissenschaftsgemeinschaft über neue Entwicklungen und Regulierungen. Sie ist Ansprechpartner für Forscher, Öffentlichkeit und andere Gremien der wissenschaftlichen Gemeinschaft und vertritt die GfV-Mitglieder bei der Umsetzung von Ethikrichtlinien und möglicher Regulierung von virologischer Forschung mit Dual-Use-Potential. Die Kommission hat weiterhin die Sensibilisierung des wissenschaftlichen Nachwuchses im Fachgebiet Virologie über Freiheiten und Verantwortung in der Wissenschaft zum Ziel.


PD Dr Jens Bohne

Hannover Medical School (Hannover Medical School)
Institute of Virology, OE5230
Carl-Neuberg-Str. 1
30625 Hannover

Tel: +49 511 532 4307


Dr Linda Brunotte
Centre for Molecular Biology of Inflammation
Von-Esmarch-Straße 56
48149 Münster

Tel: +49 251 83 52213


Prof. Dr. Stephan Ludwig, Münster
Prof. Dr. Klaus Osterrieder, Berlin
Prof. Dr. Martin Schwemmle, Freiburg
Prof. Dr. Thomas Vahlenkamp, Leipzig
Prof. Dr. Thorsten Wolff, Berlin

Dr. Sabine Dudek, Tübingen (zur Zeit inaktiv)
Prof. Dr. Thomas Mettenleiter, Greifswald, Insel Riems (ehrenamtlich)

Further information

DURC Commission of the GfV "Research with Dual-Use Potential in Virology"
The experiments of Fouchier and Kawaoka on altering the transmissibility of highly pathogenic influenza viruses have caused a great stir worldwide. In the field of virology, in particular, a multifaceted debate on safety aspects in research ("Dual Use Research of Concern - DURC") has flared up as a result. In infectious biology, the term DURC stands for research on certain human pathogens which potentially harbours the danger that the research results could also be misused for the development of bioweapons or for bioterrorist purposes. DURC is usually accompanied by an experimental design in which biological properties of a pathogen are changed ("gain-of-function"). For example, the ability to multiply, the transmissibility or the host spectrum of critical pathogens are changed experimentally. These changes could then lead to, among other things, increased pathogenicity or altered host tropism of a pathogen. However, DURC does not only affect infection research but also many other areas in research and development.

There is currently a discussion about which activities are necessary to better assess the benefits and risks of such research. Furthermore, the question arises whether and how current safety standards must be adapted to new requirements without research work being fundamentally inhibited by excessive safety measures. Politicians have already become active in this debate and new guidelines for regulating safety-relevant research are currently being discussed. In order to provide professional support for this exchange of ideas, the participation of the scientific community is particularly important. For this reason, the Society of Virology has formed a commission to accompany research with dual-use potential in virology.

The goals and work programme of this commission are:

To keep the virological scientific community informed about new developments and regulations as well as meetings and conferences in Germany, Europe and the USA on this topic.
To represent the interests of GfV members in the implementation of ethical guidelines and possible regulation of virological research with dual-use potential, e.g. by preparing statements.
To be the point of contact for researchers, the public and other bodies in the scientific community, such as the German Research Foundation and the National Academy of Sciences Leopoldina.
To provide specialist expertise for the assessment of research projects with dual-use potential, e.g. within the framework of ad hoc working groups according to the concept of the DFG and Leopoldina Academy
To raise awareness among young scientists in the field of virology about freedoms and responsibilities in science.

The goals of the commission were defined by the commission members. The GfV board and advisory council have agreed to these goals.

Bericht “Schneller als die Natur erlaubt” (Rheinische Post)


Genetic engineering

The "Genetic Engineering" Commission is concerned with the risk assessment of microorganisms, safety classification of genetic engineering work, necessary safety measures in genetic engineering facilities and possible risks of a release or placing on the market of genetically modified organisms (GMOs) via the "Central Commission for Biological Safety" (ZKBS). Members of the commission represent the Virology Division in the ZKBS and hold the chair of the ZKBS.


Prof. Dr. med. Sigrun Smola
Institute of Virology
Saarland University Hospital
Building 47
D-66421 Homburg/Saar
Tel: +49 6841 16-23931
Fax: +49 6841 16-23980


Prof. Dr. Ingo Drexler, Düsseldorf
Prof. Dr. Anja Ehrhardt, Witten
Prof. Dr. Edgar Maiß, Hannover
Prof. Dr. Stefan Pöhlmann, Göttingen
Prof. Dr. Sigrun Smola (Vorsitzende)
Prof. Dr. Thomas Vahlenkamp, Leipzig

Further information

Higher education affairs, research funding, international relations

The Commission "University Affairs, Research Funding, International Relations" of the GfV represents the GfV in matters concerning university affairs, research funding issues and is responsible for the GfV's relations with international professional associations.


Prof. Dr. med. Hartmut Hengel
Institute of Virology
University Hospital Freiburg
Hermann-Herder-Str. 11
79104 Freiburg
Tel: +49 (0)761 203 6534
Fax: +49 (0)761 203 6626


Prof. Dr. Christian Drosten, Berlin
Prof. Dr. Helmut Fickenscher, Kiel
Prof. Dr. Frank Kirchhoff, Ulm
Jun.- Prof. Dr. Stephanie Pfänder, Bochum
Prof. Dr. Ulrike Protzer, München
Dr. Christian Sieben, Braunschweig
PD Dr. Andrea Thoma-Kress, Erlangen
Prof. Dr. Mirko Trilling, Essen
Mitglieder des Vorstandes der GfV

further information


The joint commission "Immunisation" of the DVV and GfV deals with the most diverse aspects of vaccinations against viral infections. In this function, the commission prepares statements for various federal institutions and informs the scientific community about current developments in the field of immunisation.


Prof. Dr. rer. nat. Matthias Tenbusch
Virological Institute - Clinical and Molecular Virology
University Hospital Erlangen

Schlossgarten 4
91054 Erlangen

Tel:+49 (0) 9131 - 85 26784

Vice Chairman

Prof. Dr. med. Klaus Überla
Virological Institute - Clinical and Molecular Virology
University Hospital Erlangen

Schlossgarten 4
91054 Erlangen

Tel: +49 (0) 9131 - 85 23563


Prof. Dr Hartmut Hengel, Freiburg
Prof. Dr. Eberhard Hildt, Langen
Prof. Dr. Heidemarie Holzmann, MD, Wien
Prof. Dr. Wolfgang Jilg, Regensburg
Prof. Dr. Thomas Mertens, Ulm
Prof. Dr. Klaus Osterrieder, Berlin
Prof. Dr. Bodo Plachter, Mainz
Prof. Dr. Herbert Pfister, Köln
Dr. Hedwig Roggendorf, München
Prof. Dr. Jonas Schmidt-Chanasit, Hamburg
Prof. Dr. Gerd Sutter, München
Prof. Dr. Jörg Timm, Düsseldorf
Priv. Doz. Dr. Ole Wichmann, Berlin
Prof. Dr. Dr. Luka Cicin-Sain, Braunschweig (für die DGfI)



Teaching, further education and training

The joint commission "Teaching, Continuing Education and Training" of the DVV and GfV represents the interests of the subject virology in teaching, continuing education and training. For this purpose, it participates in the creation and adaptation of laws, licensing regulations and further training and learning objective catalogues, among other things. In addition, the commission is responsible for the certificate "Fachvirologe" of the GfV.


Prof. Dr. Helmut Fickenscher
Institute for Infectious Medicine
Christian-Albrecht-Universität zu Kiel
Brunswiker Str. 4
24105 Kiel
Tel: 0431 500 15300
Fax: 0431 500 15304


Prof. Dr Elke Bogner, Berlin
Prof. Dr Hartmut Hengel, Freiburg
Prof. Dr Christian Jassoy, Leipzig
Prof. Dr Paul Schnitzler, Heidelberg
Prof. Dr Sigrun Smola, Homburg
Prof. Dr Jörg Timm, Düsseldorf

Further information - Certificate "Fachvirologe"

Curriculum of Society of Virology for obtaining the certificate in medical virology and infection epidemiology ("Fachvirologe")

Natural scientists experienced in medical virology and infection prevention from the field of life sciences and veterinarians can acquire the Certificate for Medical Virology and Infection Prevention on the basis of a catalogue of subjects by providing evidence of the relevant qualifications and successfully completing an oral expert interview before an examination board of the GfV. This certificate documents the corresponding professional competence and thus the qualification for the technical management of a laboratory of medical virology and, as far as legally permissible, also the medical release of technically validated results of virus diagnostics.

Further information - "BSL- Workshops

BSL workshops for "Professionals" are held at regular intervals.

For activities with biological agents from protection level 3 (Biosafety Level 3, BSL-3), the Biosubstances Ordinance requires one competent person per institution. The required further training in expertise can be demonstrated by participation in the BSL-3 workshop series. Experience in the BSL-3 laboratory is required.


The joint commission "Guidelines" of the DVV and GfV contributes virological expertise to the preparation and revision of guidelines that touch on virological topics. To this end, the commission carries out a screening of submitted guidelines. Another task of the commission is the identification of guideline topics that fall within the topic area of the GfV and where the GfV should initiate the preparation of its own guidelines.


Prof. Dr. Jörg Timm
Institute of Virology
University Hospital Düsseldorf
Heinrich Heine University
Moorenstr. 5
40225 Düsseldorf

Tel: +49 (0) 211 - 81 12225


Dr. Anne Cordes, Hannover
Prof. Dr. Anna-Maria Eis-Hübinger, Bonn
Prof. Dr. Helmut Fickenscher, Kiel
Dr. Daniela Huzly. Freiburg
Priv.-Doz. Andi Krumbholz, Kiel
Dr. Nadine Lübke, Düsseldorf
Prof. Dr. Susanne Modrow, Regensburg
Prof. Dr. Hans-Helmut Niller, Regensburg
Prof. Dr. Marcus Panning, Freiburg
Dr. Susanne Pfefferle, Hamburg
Dr. Jürgen Rissland, Homburg (Saar)
Prof. Dr. Stefan Ross, Essen
Prof. Dr. Paul Schnitzler, Heidelberg

Further information

Medical guidelines are systematically developed aids for physicians for decision-making in the diagnosis, treatment and prevention of diseases. The Society of Virology supports the creation of medical guidelines by actively participating in the development process or by coordinating the creation of guidelines as the lead professional society. The Society of Virology is involved in the following guidelines:

Table Guidelines with GfV participation

News and Views

The commission "News & Views" represents the GfV externally on Twitter @GesVirology, among others. In addition to its own GfV members and the scientific community, the commission also wants to inform the interested public. Furthermore, the commission advises GfV members who would like to publish their own News & Views statements via the GfV webpage and Twitter @GesVirologie.


Dr. Marco Binder
Department "Virus-associated Carcinogenesis" (F170)
German Cancer Research Center (DKFZ)

Im Neuenheimer Feld 280
69120 Heidelberg


Dr. Emanuel Wyler
Max Delbrück Center
Berlin Institute for Medical Systems Biology

Hannoversche Street 28
10115 Berlin


Prof. Dr. Judith Aberle, Vienna
Priv. Doz. Dr. Hanna-Mari Baldauf, Munich
Prof. Dr. Stephan Becker, Marburg
Prof. Dr. Melanie Brinkmann, Braunschweig
Dr. Linda Brunotte, Münster
Dr. Victor Corman, Berlin
Prof. Dr. Isabella Eckerle, Geneva
Prof. Dr. Gisa Gerold, Hannover
Prof. Dr. Volker Lohmann, Heidelberg
Dr. Björn Meyer, Magdeburg
Dr. Christin Müller, Gießen
Prof. Dr. Thomas Pietschmann, Hannover
Dr. Cornelius Rohde, Marburg
Prof. Dr. Michael Schindler, Tübingen
Prof. Dr. Beate Sodeik, Hannover
Prof. Dr. Mirko Trilling, Düsseldorf
Prof. Dr. Friedemann Weber, Gießen
The members of the board of the GfV

Further information

National Reference Centres (NRC) and Consultant Laboratories (CL) / virological surveillance

The commission "National Reference Centres and Consultant Laboratories / Virological Surveillance" organises the regular exchange with all virological NRCs and KLs. There is also a regular exchange with the non-virological NRCs/KLs via the "Permanent Working Group of NRCs/KLs of the DGHM". In addition, the Commission, in cooperation with the GfV Board, represents the concerns of NRZs and KLs vis-à-vis the Robert Koch Institute and the Federal Ministry of Health.


Prof. Dr. med. Ulrike Wieland
Institute for Virology
University Hospital Cologne (AöR)
National Reference Centre
for Papilloma and Polyoma Viruses
Fuerst-Pueckler-Strasse 56
50935 Cologne

Tel: +49-(0)221 - 478 858 10/ 858 01
Fax: +49-(0)221 - 478 858 04


PD Dr. med. Albert Heim
Institute of Virology
Hannover Medical School
Consultant Laboratory for Adenoviruses
Carl-Neuberg-Str. 1
30625 Hannover
Tel.: +49 511-532-4311
Fax: +49 511 532 5732


National Reference Centre for Hepatitis B and D Viruses, Gießen
National Reference Centre for Hepatitis C Viruses, Düsseldorf
National Reference Centre for Influenza, Berlin
National Reference Centre for Measles, Mumps, Rubella, Berlin
National Reference Centre for Papilloma and Polyoma Viruses, Cologne
National Reference Centre for Poliomyelitis and Enteroviruses, Berlin
National Reference Centre for Retroviruses, Munich
National Reference Centre for Tropical Infectious Agents, Hamburg
Consultant Laboratory for Adenoviruses, Hanover
Consultant Laboratory for Coronaviruses, Berlin
Consultant Laboratory for Cytomegalovirus (CMV), Ulm and Tübingen
Consultant laboratory for filoviruses, Marburg
Consultant laboratory for tick-borne encephalitis (TBE), Munich
Consultant laboratory for hantaviruses, Berlin
Consultant laboratory for hepatitis A virus (HAV) and hepatitis E virus (HEV), Regensburg
Consultant laboratory for herpes simplex virus (HSV) and varicella zoster virus (VZV), Freiburg
Consultant laboratory for noroviruses, Berlin
Consultant laboratory for parvoviruses, Stuttgart
Consultant laboratory for poxviruses, Berlin
Consultant laboratory for respiratory syncytial viruses (RSV), parainfluenza viruses, metapneumoviruses, Berlin
Consultant laboratory for rotaviruses, Berlin
Consultant laboratory for rabies, Essen

RKI - National reference centres and consultant laboratories

Tierexperimentelle Forschung und Tierschutz

Die „Kommission für tierexperimentelle Forschung und Tierschutz“ ist die neuste Kommission der Gesellschaft für Virologie und bündelt die Expertise zu den rechtlichen Rahmenbedingungen und den Abläufen von Tierversuchen. Die Kommission verfasst bei Bedarf Stellungnahmen und beantwortet Anfragen zu Tierrechten oder Tierversuchen.


Dr. med. vet. Alexandra Kupke
Philipps-Universität Marburg
Institut für Virologie
Hans-Meerwein-Str. 2
35043 Marburg
Tel: 06421-28 65182


Prof. Dr. Luka Cicin-Sain
Helmholtz-Zentrum für Infektionsforschung
Virale Immunologie
Inhoffenstraße 7
38124 Braunschweig
Tel: 0531 6181 4608


Prof. Dr. Martin Beer, Greifswald – Insel Riems
Jun. Prof. Dr. Niels Lemmermann, Bonn
Dr. Kore Schlottau, Greifswald – Insel Riems
Dr. Stephanie Stanelle-Bertram, Hamburg
Prof. Dr. Asisa Volz, Hannover

Further information

Virus disinfection

The joint commission "Virus Disinfection" of the DVV and GfV informs the scientific community about new aspects and methods of virus disinfection, collaborates on statements and guidelines and represents virological expertise in a wide range of federal authorities and institutions.


Priv. Doz. Dr. Maren Eggers
Labor Prof. Gisela Enders MVZ GbR
Head of Virology
Rosenbergstr. 85
70193 Stuttgart
Tel: +49 711 6357-130
Fax: +49 711 6357-202


Dr. Sven Reiche
Friedrich Loeffler Institute
Deputy Head ATB, Head of Laboratory and Head of Bio-Bank
South shore 10
17493 Greifswald - Riems Island
Phone : +49 38351 7-1204, -1540
Fax : +49 38351 7-1524


Priv. Doz. Dr. Johannes Blümel, Langen (PEI)
Prof. Dr. Dieter Glebe, Gießen
Dr. Martin Hufbauer, Köln
Prof. Dr. Janis Müller, Marburg
Dr. Inge Schwebke, Berlin
Dr. Jochen Steinmann, Bremen
Prof. Dr. Eike Steinmann, Bochum
Prof. Dr. Miranda Suchomel, Wien (ÖGHMP)
Prof. Dr. Holger Rabenau, Frankfurt
Dr. Ingrid Rapp, Ochsenhausen
Dr. Paula Zwicker, Greifswald

Ständige Gäste:
Prof. Dr. Uwe Truyen, Leipzig (DVG e.V.)
Prof. Dr. Nils-Olaf Hübner, Greifswald (DGKH e.V.)
Prof. Dr. Reimar Johne, Berlin (BfR)
Katharina Konrat, Berlin (RKI)
Frau Dr. Viola Weinheimer, Dortmund (BAuA)
Dr. Franziska Brandt, Bonn (BfArM)

Further information

Suitable Disinfectants with Proven Efficacy for Genetically Modified Viruses and Viral Vectors (30.10.2023)

The latest publication of the Virus Disinfection Commission of the German Society for Virology and the German Association for Virus Control together with VAH facilitates the selection of the appropriate disinfectant for genetically modified organisms or viral vectors. In addition, this publication on the new claim known as “virucidal activity PLUS”, summarizing the available methods for evaluating the virucidal activity of chemical disinfectants against genetically modified organisms (GMOs). 

Joint communication from VAH and the Virus Disinfection Commission of DVV and GfV_ViruszidPlus (25.2.2023)

Hygiene and disinfection measures for monkeypox virus infections (07/25/2022).

Current requirements for virus-effective disinfectants for VAH certification (05.05.2022)

Joint communication of VAH and the Commission Virus Disinfection of DVV and GfV_Hepatitis (03.05.2022)


Virus diagnostics

The joint commission "Virus Diagnostics" of the DVV and GfV informs the scientific community about new aspects in virus diagnostics and represents virological expertise at various federal authorities, the Federal Medical Association as well as various Committees and develops statements on the current state of virus diagnostics. In the field of quality assurance, the commission works in close coordination with INSTAND e.V. and scientifically accompanies the interlaboratory tests in virus diagnostics.


PD Dr. Nadine Lübke
Universitätsklinikum Düsseldorf
Institut für Virologie
Universitätsstraße 1
40225 Düsseldorf
Tel: +49 211 81 10556


Prof. Dr. Marcus Panning
Universitätsklinikum Freiburg
Institut für Virologie
Hermann-Herder-Str. 11
79104 Freiburg
Tel: +49 761 203 6610



Holger F. Rabenau, Frankfurt
Meri Gorgievski, Bern
Albert Heim, Hannover
Hartmut Hengel, Freiburg
Marcus Panning, Freiburg (Vertreter)
Jörg Hofmann, Berlin
Thomas Mertens, Ulm
Stefan Roß, Essen
Christian G. Schüttler, Gießen
Dieter Glebe, Gießen (Vertreter)
Barbara Schmidt, Regensburg
Jürgen Wenzel, Regensburg (Vertreter)
Sigrun Smola, Homburg/Saar
Benedikt Weißbrich, Würzburg
Ulrike Wieland, Köln
Lukas Weseslindtner, Wien
Theresia Popow-Kraupp, Wien (Vertreterin)


Heinz Zeichhardt, Berlin
Claus-Thomas Böck, Berlin
Josef Eberle, München
Lutz Gürtler, München (Vertreter)
Martin Enders, Stuttgart
Rüdiger Braun, Stuttgart (Vertreter)
Helmut Fickenscher, Kiel
Barbara Gärtner, Homburg/Saar
Rolf Kaiser, Köln
Klaus Korn, Erlangen
Annette Mankertz, Berlin
Sigrid Nick, Langen
Michael Chudy, Langen (Vertreter)
Jonas Schmidt-Chanasit, Hamburg

Sandra Ciesek, Frankfurt
Daniela Huzly, Freiburg
Uwe G. Liebert, Leipzig
Martin Obermeier, Berlin
Jörg Timm, Düsseldorf
Armin Baillot, Hannover
Sabine Diedrich, Berlin
Martin Kammel, Berlin
Peter Wutzler, Jena

Further information

IVDR relevant documents

Procedural instruction / regulations and responsibilities for validation / verification in the diagnostic laboratory

Annex 1 - appropriate forms in Word format

Annex 2 - appropriate forms in PDF format

Further sample declarations, among others on conformity, handouts on "Implementation of the general requirements for performance evaluation" and on risk management, as well as a checklist on the analogy between IVDR, Annex I and ISO 15189 have been prepared by other AWMF working groups and can be found at:

Accreditation relevant documents

Model procedure instruction validation

Viral infection during pregnancy

The joint commission "Viral Infection in Pregnancy" of the DVV and GfV contributes virological expertise to the preparation and revision of guidelines that touch on viral infections in pregnancy. It prepares statements on legislative procedures and represents virological expertise in the Committee on Maternity Protection, in particular in sub-committee II (material hazards) and the working group "Biological substances" located there.


PD Dr. Corinna Pietsch
Universitätsklinikum Leipzig
Inst. f. Med. Mikrobiologie und Virologie
Fachbereich Virologie
Johannisallee 30, Haus J
04103 Leipzig
Tel: 0341 – 97 14300

Vice Chair

Dr. med. Daniela Huzly
University Hospital Freiburg
Institute of Virology
Hermann-Herder-Strasse 11
D-79104 Freiburg
Tel: 0761 203 6609
Fax: 0761 203 6603


Prof. Dr. Martin Enders, Stuttgart
Prof. Dr. Annette Mankertz, Berlin
PD Dr. Corinna Pietsch, Leipzig
Prof. Dr. Markus Knuf, Worms
Prof. Dr. Karl-Oliver Kagan, Tübingen

Virus safety in transfusion and transplantation

The joint commission "Virus Safety in Transfusion and Transplantation" of the DVV and GfV deals with general and specific problems of virus safety in transfusion and TX and prepares recommendations on current aspects of virus safety. This is done in close contact with the relevant professional societies, expert committees, the RKI and the PEI.


Prof. Dr. Dieter Glebe
Justus Liebig University Giessen
Institute of Medical Virology
Schubertstr. 81
35392 Giessen
Tel: +49 641 99 41246
Fax: +49 641 99 41209


PD Dr. Johannes Blümel, PEI, Langen (deputy)
Prof. (ret.) Dr. Joachim Denner, FU Berlin
Prof. Dr. Dieter Glebe, JLU, Gießen (chair)
PD Dr. Sven Pischke, UKE, Hamburg
Prof. Dr. Eike Steinmann, RUB, Bochum


Zoonoses and viral infections of animals

The Commission "Zoonoses and Virus Infections of Animals" is composed of representatives of the responsible federal authorities PEI, RKI and FLI, the National Research Platform for Zoonoses and representatives of the field of virology at the five veterinary medical educational institutions in Germany. It coordinates the GfV's cooperation with the federal authorities and the National Research Platform for Zoonoses and informs the scientific community about current topics in this field.


Prof. Dr. Asisa Volz
Stiftung Tierärztliche Hochschule Hannover
Institut für Virologie
Bünteweg 2
30559 Hannover
Tel: +49 511 953-8857


PD Dr. Claudia Bachofen, Mittelhäusern, CH
Prof. Dr. Paul Becher, Hannover
Prof. Dr. Martin Groschup, Greifswald-Riems
Prof. Dr. Stephan Ludwig, Münster
Prof. Dr. Gisa Gerold, Hannover
PD Dr. Allison Groseth, Greifswald-Riems
PD Donata Hoffmann, Greifswald-Riems
Prof. Dr. Klaus Osterrieder, Berlin
Prof. Dr. Martin Schwemmle, Freiburg
Prof. Dr. Asisa Volz, Hannover
Prof. Dr. Friedemann Weber, Gießen


Questions, feedback, suggestions and requests for the development of Committees and its tools can be sent by mail to the e-mail address